Chimera Investment (NYSE:CIM - Get Free Report) had its target price lowered by Keefe, Bruyette & Woods from $13.00 to $11.50 in a research report issued to clients and investors on Monday, Benzinga reports. The firm presently has a "market perform" rating on the real estate investment trust's stock. Keefe, Bruyette & Woods's price objective suggests a potential upside of 57.64% from the company's previous close.
Separately, Weiss Ratings downgraded shares of Chimera Investment from a "sell (d+)" rating to a "sell (d)" rating in a research report on Friday, September 18th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $13.67.
Get Our Latest Research Report on CIM
Chimera Investment Stock Performance
Shares of NYSE CIM traded down $0.01 during trading hours on Monday, reaching $7.29. The stock had a trading volume of 1,158,172 shares, compared to its average volume of 945,955. The firm has a market cap of $610.68 million, a price-to-earnings ratio of -2.38 and a beta of 1.75. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 2.34. Chimera Investment has a fifty-two week low of $7.18 and a fifty-two week high of $14.18. The firm has a 50-day moving average of $9.68 and a 200-day moving average of $12.17.
Chimera Investment (NYSE:CIM - Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The real estate investment trust reported $0.38 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.07). The firm had revenue of ($118.00) million for the quarter, compared to analyst estimates of $103.10 million. Chimera Investment had a positive return on equity of 9.99% and a negative net margin of 19.11%.
Institutional Investors Weigh In On Chimera Investment
Several hedge funds have recently modified their holdings of the stock. StoneX Group Inc. acquired a new stake in shares of Chimera Investment in the 3rd quarter valued at approximately $220,000. International Assets Investment Management LLC boosted its stake in shares of Chimera Investment by 31.0% in the third quarter. International Assets Investment Management LLC now owns 26,695 shares of the real estate investment trust's stock valued at $250,000 after buying an additional 6,311 shares in the last quarter. Kestra Advisory Services LLC boosted its stake in shares of Chimera Investment by 167.6% in the third quarter. Kestra Advisory Services LLC now owns 34,346 shares of the real estate investment trust's stock valued at $327,000 after buying an additional 21,512 shares in the last quarter. Sigma Planning Corp boosted its stake in shares of Chimera Investment by 18.9% in the third quarter. Sigma Planning Corp now owns 18,423 shares of the real estate investment trust's stock valued at $176,000 after buying an additional 2,929 shares in the last quarter. Finally, Simplicity Wealth LLC grew its holdings in Chimera Investment by 18.1% during the third quarter. Simplicity Wealth LLC now owns 83,244 shares of the real estate investment trust's stock worth $793,000 after acquiring an additional 12,762 shares during the period. 48.44% of the stock is owned by institutional investors and hedge funds.
Chimera Investment Company Profile
(
Get Free Report)
Chimera Investment Corporation NYSE: CIM is a real estate investment trust that invests primarily in residential mortgage assets and other real estate-related investments. The company seeks to generate income from a portfolio that may include residential mortgage loans, agency and non-agency residential mortgage-backed securities, and other mortgage-related assets.
Chimera's investments can include whole residential mortgage loans and securitized interests backed by mortgages. Its portfolio has historically included both agency assets, which carry guarantees from government-sponsored entities or government agencies, and non-agency assets, which generally involve greater credit exposure.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Chimera Investment, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chimera Investment wasn't on the list.
While Chimera Investment currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.